Philips Teams Up with Three Leading Russian Research Institutes

Royal Philips ElectronicsRoyal Philips Electronics (NYSE:PHG, AEX:PHI) has embarked on a five-year joint research and development program with the Saint Petersburg State Polytechnical University, the Vavilov State Optical Institute and the Ioffe Physical Technical Institute in the field of medical imaging technologies. Philips will be investing up to EUR 2.5 million in the program, comprising direct funding and 'in-kind' support, including research staff.

The joint R&D program will focus on the development of so-called scintillation materials to improve the sensitivity of the detectors used in CT, PET and SPECT* scanners. Such scanners are typically used in the diagnosis of diseases such as cardiovascular disease and cancer. Improved detector sensitivity can ultimately be translated into shorter scan times, lower radiation doses for the patient, or enhanced image quality, depending on the application. In addition, the researchers will develop new computer algorithms for more efficient image reconstruction and processing.

The three Russian research institutes involved are all leaders in the field of scintillation materials research, and optical material production and characterization, both in Russia and on a global level. The Saint Petersburg State Polytechnical University will serve as the central hub in the joint R&D program and support in coordinating the research. It will connect the spokes as represented by the Vavilov State Optical Institute, the Ioffe Physical Technical Institute, and Philips' research laboratories in Eindhoven (The Netherlands), Hamburg (Germany) and Paris (France).

"This ambitious joint R&D program is in line with our policy of open innovation to team up with partners that possess complementary strengths," says Frans van Houten, CEO of Philips. "As a leading global player in medical imaging systems, Philips will be able to tap into Russia's scientific expertise, as well as its development and industrialization capabilities, via the three St. Petersburg-based research institutes. At the same time, I am convinced that our collaborations can catalyze growth in the Russian medical imaging industry."

"The launch of the joint R&D program in medical imaging gives an added impetus to Russian activities in this field. It is a unique opportunity for Russia’s scientific community and the universities involved to directly interact with one of the industry leaders in medical imaging," adds Andrei Rudskoy, President of the Saint Petersburg State Polytechnical University and corresponding member of the Russian Academy of Sciences. "It will also allow us to make the important step from theoretical and experimental research to advanced equipment production. The collaboration has the potential to formulate and solve the technological challenges associated with improving existing scintillation materials, detectors, image processing and reconstruction technologies, ultimately moving us towards an entirely new level in the medical equipment industry."

Recognizing that advanced R&D programs are vital to nurturing and growing any industry ecosystem, the newly established joint R&D program will feed directly into Russia's emerging medical equipment industry. It underlines Philips' commitment to collaborate with Russian partners that are leaders in specific domains in order to help modernize medical facilities in hospitals in Russia. Other examples include Philips' previous agreements with Russian companies to manufacture affordable imaging systems in Russia and the company's collaborations with Russian institutes in medical and clinical research.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

* CT: Computed Tomography; PET: Positron Emission Tomography; SPECT: Single Photon Emission Computed Tomography

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...